✦ LIBER ✦

A six-month, open-label study assessing a new formulation of leuprolide 7.5 mg for suppression of testosterone in patients with prostate cancer

✍ Scribed by Ramon Perez-Marreno; Franklin M. Chu; Donald Gleason; Edward Loizides; Barton Wachs; Robert C. Tyler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness, pharmacokinetics, and saf

✍ Michael Marberger; Amir V Kaisary; Neal D. Shore; Gary S. Karlin; Claudio Savuls 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 168 KB

An eight-month clinical study of LA-2575

✍ Oliver Sartor; Martin K Dineen; Ramon Perez-Marreno; Franklin M Chu; Graham J Ca 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 114 KB

UP.34: A Comparative Head-On Efficacy St

✍ R. Sood; S. Kathuria; H. Ahmad; M. Ahir 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 95 KB

POS-03.60: A comparative head on efficac

✍ R. Sood; S. Kathuria 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 72 KB

The efficacy and safety of degarelix: a

✍ Laurence Klotz; Laurent Boccon-Gibod; Neal D. Shore; Cal Andreou; Bo-Eric Persso 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

Duration of Testosterone Suppression aft

✍ Bill Pettersson; Eberhard Varenhorst; Anssi Petas; Jürgen Sandow 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 176 KB